Title : Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics - da Cruz Freire_2022_3.Biotech_12_344 |
Author(s) :
da Cruz Freire JE , Jnior JEM , Pinheiro DP , da Cruz Paiva Lima GE , do Amaral CL , Veras VR , Madeira MP , Freire EBL , Ozrio RG , Fernandes VO , Montenegro A , Montenegro RC , Colares JKB , Jnior RMM |
Ref :
3 Biotech , 12 :344 , 2022 |
Abstract : da Cruz Freire_2022_3.Biotech_12_344 |
ESTHER : da Cruz Freire_2022_3.Biotech_12_344 |
PubMedSearch : da Cruz Freire_2022_3.Biotech_12_344 |
PubMedID: 36382241 |